U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528053) titled 'A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants' on April 07.
Brief Summary: A Phase 1 Clinical Study Of BW-20805-2-1001 in Healthy Participants
Study Start Date: April 28
Study Type: INTERVENTIONAL
Condition:
HV
Intervention:
DRUG: BW-20805
Cohort 1 will receive SC administrations of BW-20805 on Day1.
DRUG: BW-20805
Group 2 will receive SC administrations of BW-20805 on Day1
DRUG: BW-20805-2
Group 3 will receive SC administrations of BW-20805-2 on Day1.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission...